PreveCeutical Medical, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA74141E1043
CAD
0.03
0.01 (25.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PreveCeutical Medical, Inc. stock-summary
stock-summary
PreveCeutical Medical, Inc.
Pharmaceuticals & Biotechnology
Preveceutical Medical Inc is a Canada-based company engaged in pharmaceutical sector. The Company is focused on preventive health sciences. The Company has partnered with the University of Queensland in multiple research and development programs. The Company has one product for sale, the CELLB9 R Immune System Booster, which is an oral dilute solution infused with select peptides sourced exclusively from Caribbean Blue Scorpion venom. The active potentiated ingredients in CELLB9R support health at a deep cellular level and are used in over 40 countries for well over a decade.
Company Coordinates stock-summary
Company Details
1177 West Hastings Street, Suite 2200 , VANCOUVER BC : V6E 2K3
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 19 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.63

stock-summary
Return on Equity

36.03%

stock-summary
Price to Book

-2.63